A few days after a report on his expected savings, the director of health insurance, Thomas Fatôme, pointed out on Monday “the weight of chronic diseases” in his expenses. The trend is confirmed year after year: “We see a concentration of health spending around chronic diseases,” he said in a press release on the new website “Data pathologies” tracing reimbursements for 57 categories of diseases , by region or department, from 2015 to 2020.
The most recent figures show a total of 168 billion spent on the care of more than 66 million patients, including 104 billion for chronic diseases, or 62%. A part in the progression of a point of reference with 2019, essential due to the fall of the “punctual” hospitalizations during the confinements due to the first waves of Covid-19.
The number of patients has increased
Several analyzes over several years have highlighted the “extremely heavy factors that push up”, the soul of Thomas Fatôme. In five years, the number of patients has increased by 440,000 for diabetes and 540,000 for cardiovascular disease.
At the same time, the cost of treatment was 18% for “active phase cancer” and up to 50% for lung cancer, with the arrival of new treatments as immunotherapy. “Good news for patient care,” said the Health Insurance boss, who said he was “not here to say it’s too expensive, but to make it clear.”
A kind of land preparation before the annual report “Expenses and products”, which aims to propose to the government ways to control health spending, upstream of the budget of the Secu presented in the fall. Without deflecting his expected proposals in late June or early July, he said that “the debate on health policy is all the more relevant because it is based on stagnant data”, adding that “our responsibility is to provoke this debate ”.